Has Nasser Abu-Erreish received payments from drug or device companies?

Yes. Drug and device makers reported $2,378 in general payments to Nasser Abu-Erreish across 139 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nasser Abu-Erreish did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nasser Abu-Erreish come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nasser Abu-Erreish

Hematology & Oncology · Klamath Falls, ORNPI 1205811940

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,920 of the $2,378 with a category attached, or 80.7%. It is spread thinly across 44 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,060 and has fallen 74.1% since, to $274 in 2022.

$2,378in general payments, 2019–2025

Across 139 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Seagen Inc.$325
AstraZeneca$193
Johnson & Johnson$186
E.r. Squibb & Sons, L.L.C.$149
Clovis Oncology, Inc.$138
Amgen$134
plus $1K from 38 others

What the payments were for

Food & beverage$1,92081%
Education$45819%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Seagen Inc.	17	$325
AstraZeneca	13	$193
Johnson & Johnson(2 entities)	7	$186
E.r. Squibb & Sons, L.L.C.	10	$149
Clovis Oncology, Inc.	5	$138
Amgen	9	$134
Boston Scientific	1	$108
Daiichi Sankyo Inc.	4	$84
Bristol Myers Squibb	5	$83
Merck	6	$79
Sanofi	5	$74
Novartis	4	$53
Takeda Pharmaceuticals U.S.A., Inc.	3	$52
GSK	3	$45
Boehringer Ingelheim	3	$44
Dova Pharmaceuticals	3	$41
Genentech USA, Inc.	2	$38
Eisai Inc.	2	$37
Gilead(2 entities)	3	$37
Agios Pharmaceuticals, Inc.	2	$36
Incyte Corporation	3	$36
Servier Pharmaceuticals LLC	2	$32
Pfizer	2	$29
Acrotech Biopharma Inc.	2	$26
Lilly USA, LLC	2	$25
Puma Biotechnology, Inc.	2	$25
Novocure Inc.	2	$23
Jazz Pharmaceuticals Inc.	1	$21
AbbVie	1	$18
AMAG Pharmaceuticals, Inc.	1	$17
Blueprint Medicines Corporation	1	$16
Astellas Pharma US Inc	1	$16
Pharmacyclics LLC, An Abbvie Company	1	$16
EUSA Pharma (US) LLC	1	$15
Karyopharm Therapeutics Inc.	1	$15
Sun Pharmaceutical Industries Inc.	1	$15
TG Therapeutics, Inc.	1	$13
Bayer	1	$13
Array Biopharma Inc	1	$12
Ipsen Biopharmaceuticals, Inc	1	$12
Foundation Medicine, Inc.	1	$12
Myovant Sciences Inc.	1	$12
Myriad Genetic Laboratories, Inc.	1	$11
EMD Serono, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

THERASPHERE$108

How this compares

$2,378 in reported general payments places this provider in the 70th percentile of 112 hematology & oncology providers in Oregon.

See all hematology & oncology providers in Oregon →

Other hematology & oncology in Klamath Falls

Brian DrukerPortland$1.9M
Bo WangCorvallis$251K
Jay AndersenPortland$196K
Richard MaziarzPortland$174K
Tibor KovacsovicsPortland$119K
Christopher YasenchakEugene$102K
Elie TraerPortland$72K
Luke FletcherEugene$44K
Jeffrey MenashePortland$38K
Michael HeinrichPortland$37K

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →